AGT and Renal insufficiency: In that study, we concluded that pitavastatin exerts eNOS-independent protective actions against angiotensin II-induced cardiovascular remodeling and renal insufficiency through inhibition of the transforming growth factor- (TGF)-β 1-Smad 2/3 signaling pathway by suppression of oxidative stress [79, 80].